Huons Meditech introduces flagship aesthetics devices at Indonesia medical exhibition

Huons Group’s medical device subsidiary, Huons Meditech, showcased its flagship products at a medical exhibition in Indonesia to expand its footprint in the Southeast Asian market.

The tech company participated in the Aesthetic Medical Updates & Scientific Exhibition (Amuse) 2026 in Jakarta, Indonesia, from Friday to Sunday, Huons Meditech said on Tuesday.

Amuse is an annual international exhibition focused on medical aesthetics, plastic surgery and dermatology. The event attracts thousands of medical professionals each year, according to Huons Meditech.

At this year’s edition, Huons Meditech showcased its flagship medical device lineup: the Dermashine Duo_RF and the Premium 9-Pin Needle.

The Dermashine Duo_RF is a drug injector that combines precise delivery with radiofrequency technology. Equipped with an upgraded pressure-sensing automatic injection system, the device was made to reduce pain and minimize drug loss during procedures.

The Premium 9-Pin Needle — designed to be used with Dermashine — is a disposable microneedle for skin booster injections. It features a laser-marked rotary controller for precise depth adjustment and was engineered to reduce drug leakage and patient discomfort during treatment.

Both products have received medical device approval from Indonesia’s ministry of health.

“Participating in Amuse, Indonesia’s most interactive international scientific congress, and introducing the proven safety and efficacy of Dermashine Duo_RF to the Southeast Asian market are highly significant feats,” said Ha Chang-woo, the CEO of Huons Meditech.

“This exhibition provided an opportunity to widely promote our technological capabilities and product excellence in the Southeast Asia market and to strengthen our collaborative relationships with local partners.”

BY KIM JI-YE   [[email protected]]